772-207-3756Monday – Thursday: 9:00 AM – 3:00 PM
Friday: 9:00 AM – Noon
Saturday – Sunday: Closed
COVID-19 VACCINATIONS
To register to be put on the waitlist for COVID vaccinations, click on links below. Please note, we will contact you to make an appointment. No phone call is necessary.
AT THIS TIME WE ARE ONLY VACCINATING ST LUCIE COUNTY RESIDENTS
TO REGISTER PLEASE FILL OUT BOTH LINKS:
1. PATIENT PRE REGISTRATION FORM
2. INFORMED CONSENT FOR COVID-19 VACCINATIONS
Walk-up testing and vaccines are not permitted. You must have an appointment in advance for testing or a vaccine prior to coming to Midway.
COVID-19 TESTING REGISTRATION
PCR AND ANTIBODY TESTING AVAILABLE
RESULTS AVAILABLE WITHIN 24 HOURS
Prior to arrival at any of our locations, your appointment should be confirmed via phone or email. Once you fill out the form, we will contact you. Nothing further needs to be done. Again, for your and our safety, no walk-ins are permitted.
TO REGISTER PLEASE FILL OUT BOTH LINKS:
1. INFORMED CONSENT FOR COVID-19 TESTING
2. PATIENT PRE REGISTRATION FORM FOR COVID-19 TESTING
FEE SCHEDULE
FOR PROVIDERS ONLY
MONOCLONAL ANTIBODIES: COVID TREATMENT REGENERON INFUSION
A Regeneron Infusion can be beneficial if you are diagnosed with COVID. It is used for the treatment of mild to moderate COVID-19 in adults and pediatric patients (12 years of age or older weighing at least 40 kilograms [about 88 pounds]) with positive COVID results and who are at high risk for progressing to severe COVID-19. This includes those who are 65 years of age or older or who have certain chronic medical conditions. Regeneron (Casirivimab and imdevimab) must be administered together by intravenous (IV) infusion. Casirivimab and imdevimab are not authorized for patients who are hospitalized due to COVID-19 or require oxygen therapy due to COVID-19. A benefit of casirivimab and imdevimab treatment has not been shown in patients hospitalized due to COVID-19. Monoclonal antibodies, such as casirivimab and imdevimab, may be associated with worse clinical outcomes when administered to hospitalized patients with COVID-19 requiring high flow oxygen or mechanical ventilation. Monoclonal antibodies are laboratory-made proteins that mimic the immune system’s ability to fight off harmful pathogens such as viruses. Casirivimab and imdevimab are monoclonal antibodies that are specifically directed against the spike protein of SARS-CoV-2, designed to block the virus’ attachment and entry into human cells.
Potential candidates for Regeneron can be referred here:
Infusion referral
Scan this with your mobile Device
Infusion referral QR Code
PFIZER EUA